Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02664545 · ClinicalTrials.gov registry record · NA

Bridge-Enhanced ACL Repair vs ACL Reconstruction

A NA study of Anterior Cruciate Ligament Tear, sponsored by Miach Orthopaedics.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02664545 is a NA study of Anterior Cruciate Ligament Tear that is active but no longer recruiting, run by Miach Orthopaedics. The registered enrollment target is 100 participants, below the 221-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02664545, a NA study of Anterior Cruciate Ligament Tear, is active but no longer recruiting, sponsored by Miach Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to compare the efficacy of the Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR™) technique with the current method of treatment for anterior cruciate ligament (ACL) injuries, ACL reconstruction.

Interventions

  • DEVICE BEAR Scaffold
  • PROCEDURE Tendon Graft

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-04
Est. Completion 2028-05-31
Phase NA

Sponsor

Miach Orthopaedics

4 total trials

What the Registry Record Tells You About NCT02664545

The ClinicalTrials.gov registry entry for NCT02664545 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (55% lower). The listed sponsor is Miach Orthopaedics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 2 interventions - of which BEAR Scaffold is the first listed.

NCT02664545 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02664545 about?

NCT02664545 is a clinical study titled "Bridge-Enhanced ACL Repair vs ACL Reconstruction". The goal of this trial is to compare the efficacy of the Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR™) technique with the current method of treatment for anterior cruciate ligament (ACL) injuries, ACL reconstruction.

What is the current status of trial NCT02664545?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2016-04. Estimated completion is 2028-05-31.

What conditions does trial NCT02664545 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear.

What interventions are being tested in trial NCT02664545?

The interventions under investigation include: BEAR Scaffold (DEVICE), Tendon Graft (PROCEDURE).

Who is sponsoring clinical trial NCT02664545?

This trial is sponsored by Miach Orthopaedics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02664545 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.